Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Advances in the ability to measure chronic, active inflammation in MS using MRI and positron ...

MS research suggests the disease may be divided into two biological subtypes that differ in how early and aggressively nerve ...

NASHVILLE, Tennessee — A second-generation anti-CD40L monoclonal antibody suppresses multiple sclerosis (MS) disease activity on MRI to an uncommonly high degree, new trial data suggested. Researchers ...

By analysing MRI scans and a simple blood test from hundreds of patients, researchers identified patterns that reveal how ...

ETH Zurich researchers have developed a new method of magnetic resonance imaging (MRI) for the early detection and better monitoring of multiple sclerosis (MS). The method maps the myelin sheaths in ...

For the first time, UCL researchers have used AI to identify two biologically distinct forms of multiple sclerosis ...

An article published today in the journal Lancet Neurology evaluates the risk of recurrence of active disease in older patients with multiple sclerosis after discontinuing disease-modifying therapies.

Clinical outcomes from routine practice confirm ocrelizumab effectiveness in relapsing MS, with low rates of disability worsening over 4 years.